Plus, a surge in demand is seen for large injectable capacities across the world, making it a good fit
Patient privacy matters
Microdosing is built for everything else GLP-1s do well appetite control, metabolic improvement, and inflammatory signaling at a fraction of the dose
The truth is more nuanced than headlines suggest: while the FDA has taken enforcement actions against certain manufacturers, compounded semaglutide from licensed 503A compounding pharmacies remains a legal, regulated treatment option available across all 50 states
Note: The focus on added benefit drives continuous improvement in diabetes and obesity care, fostering a healthcare environment where patients, providers, and payers all benefit from advances in clinical practice and evidence-based treatment
doi: 10.5925/jnsv1954.11.253 250